Exploring Cardiovascular Involvement in Tuberous Sclerosis: Insights for Pediatric Clinicians

Cecilia Lazea1,2, Ioana Țaranu3, Sorana D Bolboacă3

  • 1Pediatric Clinic 1, Emergency Pediatric Hospital, Calea Moților, No. 68, 400370 Cluj-Napoca, Romania.

PubMed

Insights

Tuberous sclerosis can affect children's hearts, causing cardiac rhabdomyomas and arrhythmias. Early pediatrician recognition and management of these cardiovascular issues improve quality of life.

Area of Science:

  • Pediatrics
  • Cardiology
  • Genetics

Background:

  • Tuberous sclerosis is a rare genetic disorder primarily affecting the nervous and cardiovascular systems.
  • Cardiovascular manifestations, including cardiac rhabdomyomas and arrhythmias, are common in children with tuberous sclerosis.
  • Early identification of cardiac issues is crucial for effective management and improved patient outcomes.

Purpose of the Study:

  • To equip pediatric practitioners with current knowledge on cardiovascular complications in children with tuberous sclerosis.
  • To review the evolution of cardiovascular manifestations from antenatal to postnatal stages.
  • To outline strategies for systematic screening and long-term follow-up of cardiac rhabdomyomas and arrhythmias.

Main Methods:

  • Literature review focusing on cardiovascular manifestations in tuberous sclerosis.
  • Overview of antenatal and postnatal cardiac feature evolution.
  • Discussion of screening and follow-up protocols for cardiac rhabdomyomas and arrhythmias.

Main Results:

  • Cardiac rhabdomyomas and arrhythmias are often the initial cardiac signs of tuberous sclerosis.
  • Clinical manifestations of cardiac rhabdomyomas can be diverse, posing diagnostic challenges.
  • Understanding the progression of cardiovascular issues aids in timely intervention.

Conclusions:

  • Pediatricians play a vital role in the early recognition of cardiovascular complications in tuberous sclerosis.
  • A systematic approach to screening and long-term follow-up is essential for managing cardiac rhabdomyomas and arrhythmias.
  • Enhanced knowledge empowers practitioners to improve the quality of life for affected children.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
321
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
177
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
157
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
231
Imaging Studies for Cardiovascular System III: X-Ray01:20

Imaging Studies for Cardiovascular System III: X-Ray

The most common cardiovascular diagnostic test is an X-ray. It produces images of the heart, blood vessels, and adjacent structures.
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
171